Filing Details
- Accession Number:
- 0001127602-17-023606
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-14 16:21:57
- Reporting Period:
- 2017-07-14
- Filing Date:
- 2017-07-14
- Accepted Time:
- 2017-07-14 16:21:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711404 | Cooper Companies Inc | COO | Ophthalmic Goods (3851) | 942657368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1182669 | L Paul Remmell | 6140 Stoneridge Mall Drive Suite 590 Pleasanton CA 94588 | Pres & Ceo - Coopersurgical | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-14 | 6,186 | $95.74 | 6,186 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-14 | 3,122 | $119.89 | 9,308 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-14 | 1,338 | $162.28 | 10,646 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-14 | 9,294 | $248.46 | 1,352 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-07-14 | 6,186 | $0.00 | 6,186 | $95.74 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-07-14 | 3,122 | $0.00 | 3,122 | $119.89 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-07-14 | 1,338 | $0.00 | 1,338 | $162.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,124 | 2022-12-11 | No | 4 | M | Direct | |
| 4,683 | 2023-12-11 | No | 4 | M | Direct | |
| 5,351 | 2024-12-09 | No | 4 | M | Direct |
Footnotes
- The sale price represents an average of sale prices between $248.1300 and $248.9100.
- 12/12/12 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/12/13; 1/5 shall vest on 12/12/14; 1/5 shall vest on 12/12/15; 1/5 shall vest on 12/12/16; and 1/5 shall vest on 12/12/17.
- 12/11/13 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/11/14; 1/5 shall vest on 12/11/15; 1/5 shall vest on 12/11/16; 1/5 shall vest on 12/11/17; and 1/5 shall vest on 12/11/18.
- 12/9/14 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/9/15; 1/5 shall vest on 12/9/16; 1/5 shall vest on 12/9/17; 1/5 shall vest on 12/9/18; and 1/5 shall vest on 12/9/19.
Billionaire Hedge Funds
